Schedule 13D ownership disclosure

Intellia Therapeutics Inc

Security class unavailable · CUSIP: 45826J105

Event date: 2020-02-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,352,295
Percent of class
8.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-040260
Form type
SC 13D/A
Filer
Intellia Therapeutics, Inc.
CIK
CIK 1652130
Filed
Mar 30, 2020
Reporting period
Feb 27, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub